Previous 10 | Next 10 |
2024-03-20 11:43:37 ET More on Exscientia Exscientia: A Strategic Hold In The AI-Driven Drug Discovery Sector (Rating Downgrade) Anagenex expands leadership team with appointment of Adrian Schreyer as CTO Exscientia CEO terminated from position due to inappropriate c...
Company to host conference call and webcast on March 21, 2024, at 12:30 p.m. GMT / 8:30 a.m. EDT Exscientia plc (Nasdaq: EXAI) will report financial results for the fourth quarter and full year ended December 31, 2023, on Thursday, March 21, 2024, before the open of U.S. markets. The Co...
2024-03-12 15:08:43 ET More on S&P 500 Index: The Great Paradox Of The U.S. Market Stocks Rally As Implied Volatility Drops Following Hot CPI Report February CPI: Back-To-Back Hot Inflation May Extend The Fed's Pause Nasdaq, S&P, Dow climb as latest C...
2024-02-25 20:48:41 ET Summary Exscientia's stock has been stagnant, with a 22% drop after the termination of its CEO due to inappropriate conduct. The company's pipeline efforts include CDK7 inhibitor GTAEXS617 and LSD1 inhibitor EXS74539, with clinical trials starting this year....
2024-02-22 14:41:34 ET More on Amgen, Eli Lilly, etc. Pfizer's Post-Pandemic Pivot Pfizer: Turnaround Is Gaining Momentum Eli Lilly: Yes, It Is Too Late To Join The Party Novo to face Wegovy competition in India as local versions loom: Reuters Weight-...
2024-02-14 02:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-02-13 16:23:45 ET Read the full article on Seeking Alpha For further details see: Exscientia CEO terminated from position due to inappropriate conduct - filing
NEW YORK, NY / ACCESSWIRE / February 13, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Exscientia plc ("Exscientia" or "the Company") (NASDAQ:EXAI). Investors who purchased Exscientia securities are encouraged to obtain additional info...
2024-02-12 08:34:12 ET DIH Holdings US ( DHAI ) +115% . Millennium Group International ( MGIH ) +111% . Beamr Imaging ( BMR ) +72% NVIDIA team up to accelerate adoption of the newest video standard - AV1. ContextLogic ( WISH ) +38%...
2024-02-08 08:45:25 ET Hitek Global ( HKIT ) +524% . CCSC Technology International ( CCTG ) +110% . Bit Brother ( BETS ) +74% . China SXT Pharmaceuticals ( SXTC ) +69% . MicroCloud Hologram ( HOLO ) +52% ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-27 08:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Maximises upside potential of precision-designed GTAEXS617 with purchase of rights from GT Apeiron Monotherapy dose escalation data readout for ELUCIDATE Phase 1/2 trial on track for second half of 2024 Combination dose escalation study starting with HR+/HER2- breast cancer to com...
— State-of-the-art platform, built using Amazon Web Services technologies, integrates generative AI drug design and robotic lab automation to further accelerate Exscientia’s ability to deliver high quality drug candidates at faster speed and lower cost — Exscientia ...